Oxford BioDynamics (OBD) is a health-care service company with a proprietary diagnostic platform technology, EpiSwitch™, based on the latest advances in the mechanisms of gene expression, non-coding RNA and epigenetics.
The EpiSwitch™ diagnostic platform technology offers a highly effective means of new product development for applications in screening, early detection, monitoring and prognosis of disease and chronic conditions associated with aberrant gene expression such as Cancer and Neurodegenerative diseases.
The Oxford BioDynamics holding company is registered in England and Wales, with subsidiaries in Singapore and Australia.
